Silence Therapeutics (SLN) Current Leases (2019 - 2026)
Silence Therapeutics (SLN) reported Current Leases of $93000.0 for Q1 2026, up 55.0% on a YoY basis from $60000.0 in Q1 2025, and up 4.49% sequentially from $89000.0 in Q4 2025.
Silence Therapeutics (SLN) Current Leases (2019 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 8 years of Current Leases data on file, last reported at $93000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 55.0% year-over-year to $93000.0; the trailing twelve-month figure through Mar 2026 stood at $93000.0 (up 55.0% YoY), and the FY2025 full-year result was $89000.0, down 23.93% from the prior year.
- Current Leases rose to $93000.0 in Q1 2026, from $89000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $523126.0 in Q4 2022 to a low of $60000.0 in Q1 2025.
- A 5-year average of $169898.9 and a median of $93000.0 in 2026 frame the typical range for Current Leases.
- Across the five-year window, Current Leases jumped 183.26% in 2022 and slumped 57.53% in 2023, its largest moves.
- Tracing SLN's Current Leases over 5 years: stood at $523126.0 in 2022, then tumbled by 57.53% to $222166.2 in 2023, then slumped by 47.34% to $117000.0 in 2024, then retreated by 23.93% to $89000.0 in 2025, then rose by 4.49% to $93000.0 in 2026.
- Business Quant data shows SLN's Current Leases at $93000.0 in Q1 2026, $89000.0 in Q4 2025, and $85000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | 93,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93,000.00 |
| Dec 31, 2025 | 89,000.00 |
| Sep 30, 2025 | 85,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 117,000.00 |
| Dec 31, 2023 | 222,166.19 |
| Dec 31, 2022 | 523,126.03 |
| Dec 31, 2021 | 184,677.45 |
| Dec 31, 2020 | 450,273.79 |
| Dec 31, 2019 | 369,003.05 |